Cargando…

SAT-432 MTD201 Has a Favourable 28-Day Sustained Release Profile Compared to Sandostatin LAR in Healthy Subjects

A double-blind, randomised, single-dose parallel group study was performed to compare the tolerability, pharmacokinetics and pharmacodynamics of MTD201 30 mg octreotide (test product) and Sandostatin LAR 30 mg (reference product) in healthy subjects. MTD201 uses Q-Sphera™ printing technology to prec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seaman, Paul, Damment, Stephen, Bamsey, Katherine, Dryja, Anna, Cook, Craig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552328/ http://dx.doi.org/10.1210/js.2019-SAT-432

Ejemplares similares

SUN-LB47 Extended Release Octreotide Pharmacokinetics in Healthy Subjects After Subcutaneous Injection of MTD201
por: Seaman, Paul, et al.
Publicado: (2020)

SAT-435 Optimization of Pharmacological Treatment of Acromegaly: Impact on IGF-1 Levels Comparing Isolated Octreotide LAR and Combined Pharmacological Therapy
por: Naves, Luciana, et al.
Publicado: (2019)

MON-432 Symptomatic Pituitary Metastases: A Report of 16 Cases
por: Loto, Monica, et al.
Publicado: (2019)

SUN-432 A Case of Sellar Plasmacytoma Masquerading as Pituitary Carcinoma with Hypopituitarism
por: Lee, Christine, et al.
Publicado: (2019)

SAT226 A Case Of Congenital Hypopituitarasim Has The Genetic And Phenotypic Features Of Orofacial Syndrome
por: Aljasser, Abdullah Abdulruhman, et al.
Publicado: (2023)

SAT-289 Evidence That Combined Pituitary Hormone Deficiency Frequently Has a Digenic/Oligogenic Etiology
por: Jee, Youn Hee, et al.
Publicado: (2020)

SAT602 The Regulation Of Food Intake Via Gastrointestinal Receptors
por: Bethea, Maigen Michelle, et al.
Publicado: (2023)

SAT-443 Osilodrostat Has No Clinically Relevant Effect on the Pharmacokinetic (PK) Profile of a Monophasic Oral Contraceptive in Healthy Females Receiving Cortisol Replacement Therapy
por: Breitschaft, Astrid, et al.
Publicado: (2019)

SAT-451 Acromegaly and Thyroid Cancer
por: Danilowicz, Karina, et al.
Publicado: (2019)

SAT-257 Coexisting Craniopharyngioma and Acromegaly
por: Yang, Almira, et al.
Publicado: (2020)

SAT-273 Case of Mistaken Identity?
por: Pla, Carlos
Publicado: (2020)

SAT-270 Priapism Secondary to Cabergoline
por: Amir, Maryam, et al.
Publicado: (2020)

SAT624 Neurosarcoidosis Presenting With Panhypopituitarism
por: Niedzialkowska, Ewelina Marta, et al.
Publicado: (2023)

MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
por: Chiloiro, Sabrina, et al.
Publicado: (2020)

Real-World Experience With Pasireotide Lar in Acromegaly Resistant to First-Generation Somatostatin Analogs: A Single Center 1-Year Observation
por: Stelmachowska-Banas, Maria, et al.
Publicado: (2021)

SAT-481 TSH Adenoma: An Elusive Diagnosis
por: Chaudhary, Hira, et al.
Publicado: (2019)

SAT623 Everolimus For Treatment-refractory Prolactinomas
por: Lin, Andrew L, et al.
Publicado: (2023)

SUN-LB075 Effects of Pegvisomant and Pasireotide LAR on Incidence of Vertebral Fractures in Patients with Acromegaly Resistant to Treatment with First-Line Somatostatin Analogs
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

SAT-480 Clinical Cases TSH Secreting Adenomas
por: Calasans, Camila, et al.
Publicado: (2019)

SAT-478 Successful Management of an Atypical Prolactinoma with Radiotherapy
por: Bowes, Christa, et al.
Publicado: (2019)

SAT-487 Unusual Case of Plurihormonal Pituitary Macroadenoma
por: Allehaibi, Ebtesam, et al.
Publicado: (2019)

SAT-454 Isolated ACTH Deficiency Due to Pembrolizumab
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2019)

SAT-403 Palmitoleate Reverses Palmitate-Induced Autophagy
por: Reginato, Andressa, et al.
Publicado: (2019)

SAT-240 Hypothalamic Lipoma and Growth Hormone Deficiency
por: Rochtus, Anne Maria, et al.
Publicado: (2020)

SAT-252 A Rare Case of Crooke’s Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2020)

SAT-267 Pregnancy in Acromegaly: Report of Five Cases
por: Burcea, Iulia Florentina, et al.
Publicado: (2020)

SAT-277 A Fierce Presentation of Cushing Disease
por: Al Sabie, Farah Laith, et al.
Publicado: (2020)

SAT616 Differentiating Resistant Prolactinoma From Macroprolactinemia
por: Lacount, Steven, et al.
Publicado: (2023)

SAT612 Granulomatous Mastitis: An Unusual Presentation Of Prolactinoma
por: Alkaissi, Hussam R, et al.
Publicado: (2023)

SAT601 The Role Of The Melanocortin System In Ovine Puberty
por: Aerts, Eliana G, et al.
Publicado: (2023)

MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR
por: Reyes-Vidal, Carlos, et al.
Publicado: (2020)

SAT-477 Pituitary Carcinoma Arising from a Macroprolactinoma
por: Gammoh, Emily, et al.
Publicado: (2019)

SAT-479 Hyperprolactinemia in a Patient with Multiple Possible Causes
por: Hosein, Rachael, et al.
Publicado: (2019)

SAT-LB083 Pituitary Apoplexy: What a Headache!
por: Perez Garcia, Yanet, et al.
Publicado: (2019)

SAT-427 Low Chloride Transporter Expression in Vasopressin Neurons
por: Fisher, Marc, et al.
Publicado: (2019)

SAT-448 Pituitary Tumors in the Eldery: An Important and Underdiagnosed Condition
por: Rosa, Isabella, et al.
Publicado: (2019)

SAT-456 Heterogeneity of Macroprolactin in Samples Suspected of False Hyperprolactinemia
por: Nguyen, Khanh Quynh, et al.
Publicado: (2019)

SAT-249 Polyarticular Osteoarthritis: A Disabling Manifestation of Acromegaly
por: Khan, Azkia, et al.
Publicado: (2020)

SAT-258 Surprising Transformation of a Microprolactinoma to a Macroprolactinoma
por: Athonvarangkul, Diana, et al.
Publicado: (2020)

SAT-255 Pituitary Adenoma With TSH and GH Co Secretion
por: Riquelme, Romina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_di2atut6ugnaihkujt10cu9vr2